These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28293155)

  • 1. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.
    Aldukhayel A
    Int J Health Sci (Qassim); 2017; 11(1):1-4. PubMed ID: 28293155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
    Thipsawat S
    Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.
    Asghar S; Asghar S; Mahmood T; Bukhari SMH; Mumtaz MH; Rasheed A
    Cureus; 2023 Aug; 15(8):e43190. PubMed ID: 37692611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.
    Riaz A; Asghar S; Shahid S; Tanvir H; Ejaz MH; Akram M
    Cureus; 2024 Mar; 16(3):e55478. PubMed ID: 38571859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Progression and Associations of Microvascular Complications in Diabetic Patients: A Study From South India.
    Ca J; Kumar Pinnelli VB; Nikethan D; Ramachandran V; Ganaraja VH; S SA; P SS; Dandu S; Sarkar D
    Cureus; 2022 Oct; 14(10):e30201. PubMed ID: 36381755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
    Ruilope LM; Segura J
    Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.
    Prakash J; Patel PS; Iqbal M; Sharma SS; Singh S; Agrawal NK; Singh U
    J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for the development of diabetic nephropathy].
    Antić M; Jotić A; Radović M; Seferović JP; Lalić NM; Jovanović D; Lezaić V
    Srp Arh Celok Lek; 2009; 137(1-2):18-26. PubMed ID: 19370961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.
    Zhuo L; Zou G; Li W; Lu J; Ren W
    Eur J Med Res; 2013 Feb; 18(1):4. PubMed ID: 23432977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates.
    Al-Maskari F; El-Sadig M; Obineche E
    BMC Nephrol; 2008 Jan; 9():1. PubMed ID: 18230135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection and treatment of diabetic nephropathy.
    Woredekal Y
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():999-1004. PubMed ID: 18806717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus.
    Krairittichai U; Potisat S; Jongsareejit A; Sattaputh C
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S1-5. PubMed ID: 21717870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
    Hunsicker LG
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S12-7. PubMed ID: 15369420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy: Is it time yet for routine kidney biopsy?
    Gonzalez Suarez ML; Thomas DB; Barisoni L; Fornoni A
    World J Diabetes; 2013 Dec; 4(6):245-55. PubMed ID: 24379914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in diabetic nephropathy: Present and future.
    Currie G; McKay G; Delles C
    World J Diabetes; 2014 Dec; 5(6):763-76. PubMed ID: 25512779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.